# LAmbre™ Left Atrial Appendage Closure System Follow-Up Study

> **NCT03693092** · — · UNKNOWN · sponsor: **Lifetech Scientific (Shenzhen) Co., Ltd.** · enrollment: 156 (estimated)

## Conditions studied

- Atrial Fibrillation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03693092
- **Lead sponsor:** Lifetech Scientific (Shenzhen) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-11-20
- **Primary completion:** 2020-04
- **Final completion:** 2020-07
- **Target enrollment:** 156 (ESTIMATED)
- **Last updated:** 2018-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03693092

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03693092, "LAmbre™ Left Atrial Appendage Closure System Follow-Up Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03693092. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*